Galectin-9 in tumor biology: a jack of multiple trades
- PMID: 23648450
- DOI: 10.1016/j.bbcan.2013.04.006
Galectin-9 in tumor biology: a jack of multiple trades
Abstract
Galectin family members have been shown to exert multiple roles in the context of tumor biology. Several recent findings support a similar multi-faceted role for galectin-9. Galectin-9 expression is frequently altered in cancer as compared to normal tissues. In addition, an increasing amount of evidence suggests that galectin-9 is involved in several aspects of tumor progression, including tumor cell adhesion and survival, immune escape and angiogenesis. Also, galectin-9 shows potential as a prognostic marker and a therapeutic target for several malignancies. In this review we summarize both the established and the emerging roles of galectin-9 in tumor biology and discuss the potential application of galectin-9 in anti-cancer therapy.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Role of Galectins in Tumors and in Clinical Immunotherapy.Int J Mol Sci. 2018 Feb 1;19(2):430. doi: 10.3390/ijms19020430. Int J Mol Sci. 2018. PMID: 29389859 Free PMC article. Review.
-
Galectin-9 in cancer therapy.Recent Pat Endocr Metab Immune Drug Discov. 2013 May;7(2):130-7. doi: 10.2174/1872214811307020006. Recent Pat Endocr Metab Immune Drug Discov. 2013. PMID: 23514536 Review.
-
Cancer Therapy Due to Apoptosis: Galectin-9.Int J Mol Sci. 2017 Jan 1;18(1):74. doi: 10.3390/ijms18010074. Int J Mol Sci. 2017. PMID: 28045432 Free PMC article. Review.
-
Unraveling galectin-1 as a novel therapeutic target for cancer.Cancer Treat Rev. 2014 Mar;40(2):307-19. doi: 10.1016/j.ctrv.2013.07.007. Epub 2013 Aug 1. Cancer Treat Rev. 2014. PMID: 23953240 Review.
-
Impact of Galectins in Resistance to Anticancer Therapies.Clin Cancer Res. 2020 Dec 1;26(23):6086-6101. doi: 10.1158/1078-0432.CCR-18-3870. Epub 2020 Jul 24. Clin Cancer Res. 2020. PMID: 32709716 Review.
Cited by
-
Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer.PLoS One. 2015 Jun 12;10(6):e0129119. doi: 10.1371/journal.pone.0129119. eCollection 2015. PLoS One. 2015. PMID: 26066796 Free PMC article.
-
Galectin-9-An Emerging Glyco-Immune Checkpoint Target for Cancer Therapy.Int J Mol Sci. 2025 Aug 19;26(16):7998. doi: 10.3390/ijms26167998. Int J Mol Sci. 2025. PMID: 40869319 Free PMC article. Review.
-
Functional expression of Tim-3 on blasts and clinical impact of its ligand galectin-9 in myelodysplastic syndromes.Oncotarget. 2017 Oct 4;8(51):88904-88917. doi: 10.18632/oncotarget.21492. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179486 Free PMC article.
-
Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells.Aging (Albany NY). 2020 Dec 8;12(23):23478-23496. doi: 10.18632/aging.202343. Epub 2020 Dec 8. Aging (Albany NY). 2020. PMID: 33295886 Free PMC article.
-
Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?Vaccines (Basel). 2018 Nov 23;6(4):79. doi: 10.3390/vaccines6040079. Vaccines (Basel). 2018. PMID: 30477198 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials